{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:44:33Z","timestamp":1788299073472,"version":"build-2803163510"},"reference-count":46,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Russian Federation","award":["075-10-2021-113"],"award-info":[{"award-number":["075-10-2021-113"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives. Tuberculosis is a deadly bacterial disease and the second most common cause of death from monoinfectious diseases worldwide. Comprehensive measures taken by health authorities in various countries in recent decades have saved tens of millions of lives, but the number of new cases of this infection has been steadily increasing in the last few years and already exceeds 10 million new cases annually. The development of new vaccines against tuberculosis is a priority area in the prevention of new cases of the disease. mRNA vaccines have already shown high efficacy against COVID-19 and other viral infections and can currently be considered a promising field of antituberculosis vaccination. In our previous study, we assessed the immunogenicity and protective activity of several types of antituberculosis mRNA vaccines with different 5\u2032 untranslated regions, but the efficacy of these vaccines was either comparable with or lower than that of BCG. Methods. Here, we conducted a comprehensive experiment to investigate the effects of cotranscriptional capping conditions and of cap structure on the magnitude of the mRNAs\u2019 translation in HEK293T and DC2.4 cells. The most effective cap version was used to create an antituberculosis mRNA vaccine called mEpitope-ESAT6. Results and Conclusions. We compared immunogenicity and protective activity between mEpitope-ESAT6 and BCG and found that the vaccine with the new cap type is more immunogenic than BCG. Nonetheless, the increased immunogenicity did not enhance vaccine-induced protection. Thus, the incorporation of different cap analogs into mRNA allows to modulate the efficacy of mRNA vaccines.<\/jats:p>","DOI":"10.3390\/vaccines12111267","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T03:52:07Z","timestamp":1731297127000},"page":"1267","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Cap-Optimized mRNA Encoding Multiepitope Antigen ESAT6 Induces Robust Cellular and Humoral Immune Responses Against Mycobacterium tuberculosis"],"prefix":"10.3390","volume":"12","author":[{"given":"Alena","family":"Kozlova","sequence":"first","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildus","family":"Pateev","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6854-7932","authenticated-orcid":false,"given":"Galina","family":"Shepelkova","sequence":"additional","affiliation":[{"name":"Central Tuberculosis Research Institute, Moscow 107564, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vasileva","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Zakharova","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6608-7557","authenticated-orcid":false,"given":"Vladimir","family":"Yeremeev","sequence":"additional","affiliation":[{"name":"Central Tuberculosis Research Institute, Moscow 107564, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-4183","authenticated-orcid":false,"given":"Roman","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-0804","authenticated-orcid":false,"given":"Vasiliy","family":"Reshetnikov","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"key":"ref_1","unstructured":"(2024, September 22). Global Tuberculosis Report 2023. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240083851."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG Vaccination on Childhood Tuberculous Meningitis and Miliary Tuberculosis Worldwide: A Meta-Analysis and Assessment of Cost-Effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"World Health Organization (2018). BCG Vaccine: WHO Position Paper, February 2018\u2014Recommendations. Vaccine, 36, 3408\u20133410.","DOI":"10.1016\/j.vaccine.2018.03.009"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41541-024-00834-y","article-title":"Antigen Identification Strategies and Preclinical Evaluation Models for Advancing Tuberculosis Vaccine Development","volume":"9","author":"Chugh","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kazakova, A., Zhelnov, P., Sidorov, R., Rogova, A., Vasileva, O., Ivanov, R., Reshetnikov, V., and Muslimov, A. (2024). DNA and RNA Vaccines against Tuberculosis: A Scoping Review of Human and Animal Studies. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1457327"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gote, V., Bolla, P.K., Kommineni, N., Butreddy, A., Nukala, P.K., Palakurthi, S.S., and Khan, W. (2023). A Comprehensive Review of MRNA Vaccines. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032700"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Muslimov, A., Tereshchenko, V., Shevyrev, D., Rogova, A., Lepik, K., Reshetnikov, V., and Ivanov, R. (2023). The Dual Role of the Innate Immune System in the Effectiveness of MRNA Therapeutics. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914820"},{"key":"ref_8","first-page":"42","article-title":"Immunogenicity of Full-Length and Multi-Epitope MRNA Vaccines for M. tuberculosis as Demonstrated by the Intensity of T-Cell Response: A Comparative Study in Mice","volume":"3","author":"Vasileva","year":"2023","journal-title":"Bull. Russ. State Med. Univ."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/bfgp\/elab027","article-title":"Infectious Disease MRNA Vaccines and a Review on Epitope Prediction for Vaccine Design","volume":"20","author":"Cai","year":"2021","journal-title":"Brief. Funct. Genom."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Reshetnikov, V., Terenin, I., Shepelkova, G., Yeremeev, V., Kolmykov, S., Nagornykh, M., Kolosova, E., Sokolova, T., Zaborova, O., and Kukushkin, I. (2024). Untranslated Region Sequences and the Efficacy of MRNA Vaccines against Tuberculosis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020888"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1073\/pnas.0401493101","article-title":"Functional Interactions of RNA-Capping Enzyme with Factors That Positively and Negatively Regulate Promoter Escape by RNA Polymerase II","volume":"101","author":"Mandal","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"22758","DOI":"10.1074\/jbc.M111.235077","article-title":"Cap-Binding Protein Complex Links Pre-MRNA Capping to Transcription Elongation and Alternative Splicing through Positive Transcription Elongation Factor b (P-TEFb)","volume":"286","author":"Lenasi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1128\/MCB.16.6.2579","article-title":"The Cap and the 3\u2032 Splice Site Similarly Affect Polyadenylation Efficiency","volume":"16","author":"Cooke","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1021\/bi401715v","article-title":"Structure and Function of Pre-MRNA 5\u2032-End Capping Quality Control and 3\u2032-End Processing","volume":"53","author":"Jurado","year":"2014","journal-title":"Biochemistry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41594-018-0164-z","article-title":"Structural and Molecular Mechanisms for the Control of Eukaryotic 5\u2032\u20133\u2032 MRNA Decay","volume":"25","author":"Mugridge","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/j.biocel.2007.10.023","article-title":"Eukaryotic Initiation Factor 4E","volume":"40","author":"Goodfellow","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature09489","article-title":"2\u2032-O Methylation of the Viral MRNA Cap Evades Host Restriction by IFIT Family Members","volume":"468","author":"Daffis","year":"2010","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1093\/nar\/gkw551","article-title":"MRNA Capping: Biological Functions and Applications","volume":"44","author":"Ramanathan","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_19","first-page":"119","article-title":"Effects of Various MRNA-LNP Vaccine Doses on Neuroinflammation in BALB\/c Mice","volume":"6","author":"Kirshina","year":"2022","journal-title":"Bull. Russ. State Med. Univ."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tube.2004.09.014","article-title":"Direct Comparison of Low-Dose and Cornell-like Models of Chronic and Reactivation Tuberculosis in Genetically Susceptible I\/St and Resistant B6 Mice","volume":"85","author":"Radaeva","year":"2005","journal-title":"Tuberculosis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/iai.65.5.1856-1862.1997","article-title":"Induction of a Type 1 Immune Response to a Recombinant Antigen from Mycobacterium tuberculosis Expressed in Mycobacterium Vaccae","volume":"65","author":"Gares","year":"1997","journal-title":"Infect. Immun."},{"key":"ref_22","first-page":"27","article-title":"Impact of Untranslated MRNA Sequences on Immunogenicity of MRNA Vaccines against M. tuberculosis in Mice","volume":"6","author":"Shepelkova","year":"2023","journal-title":"Bull. Russ. State Med. Univ."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/s41467-021-26934-0","article-title":"A Mycobacterium tuberculosis-Specific Subunit Vaccine That Provides Synergistic Immunity upon Co-Administration with Bacillus Calmette-Gu\u00e9rin","volume":"12","author":"Woodworth","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/intimm\/dxh322","article-title":"Superior T Cell Activation by ESAT-6 as Compared with the ESAT-6\u2013CFP-10 Complex","volume":"17","author":"Marei","year":"2005","journal-title":"Int. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1383098","DOI":"10.3389\/fimmu.2024.1383098","article-title":"The Role of ESAT-6 in Tuberculosis Immunopathology","volume":"15","author":"Passos","year":"2024","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.tim.2004.09.007","article-title":"ESAT-6 Proteins: Protective Antigens and Virulence Factors?","volume":"12","author":"Brodin","year":"2004","journal-title":"Trends Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A Multistage Tuberculosis Vaccine That Confers Efficient Protection before and after Exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lu, J., Guo, X., Wang, C., Du, W., Shen, X., Su, C., Wu, Y., and Xu, M. (2022). Therapeutic Effect of Subunit Vaccine AEC\/BC02 on Mycobacterium tuberculosis Post-Chemotherapy Relapse Using a Latent Infection Murine Model. Vaccines, 10.","DOI":"10.3390\/vaccines10050825"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Tkachuk, A.P., Gushchin, V.A., Potapov, V.D., Demidenko, A.V., Lunin, V.G., and Gintsburg, A.L. (2017). Multi-Subunit BCG Booster Vaccine GamTBvac: Assessment of Immunogenicity and Protective Efficacy in Murine and Guinea Pig TB Models. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176784"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lukeman, H., Al-Wassiti, H., Fabb, S.A., Lim, L., Wang, T., Britton, W.J., Steain, M., Pouton, C.W., Triccas, J.A., and Counoupas, C. (2024). A Lipid Nanoparticle-MRNA Vaccine Provides Potent Immunogenicity and Protection against Mycobacterium tuberculosis. bioRxiv.","DOI":"10.1101\/2024.07.31.605765"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/IAI.72.11.6324-6329.2004","article-title":"RNA Encoding the MPT83 Antigen Induces Protective Immune Responses against Mycobacterium tuberculosis Infection","volume":"72","author":"Xue","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Larsen, S.E., Erasmus, J.H., Reese, V.A., Pecor, T., Archer, J., Kandahar, A., Hsu, F.-C., Nicholes, K., Reed, S.G., and Baldwin, S.L. (2023). An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis. Vaccines, 11.","DOI":"10.3390\/vaccines11010130"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lorenzi, J.C., Trombone, A.P., Rocha, C.D., Almeida, L.P., Lousada, R.L., Malardo, T., Fontoura, I.C., Rossetti, R.A., Gembre, A.F., and Silva, A.M. (2010). Intranasal Vaccination with Messenger RNA as a New Approach in Gene Therapy: Use against Tuberculosis. BMC Biotechnol., 10.","DOI":"10.1186\/1472-6750-10-77"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/gen.39.05.17","article-title":"RNA Epitranscriptome: Role of the 5\u2032 Cap: Producing superior mRNA therapeutics through optimized capping","volume":"39","author":"McCaffrey","year":"2019","journal-title":"Genet. Eng. Biotechnol. News"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.omtn.2022.01.004","article-title":"Chemical Modification of Uridine Modulates MRNA-Mediated Proinflammatory and Antiviral Response in Primary Human Macrophages","volume":"27","author":"Moradian","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/nar\/gkaa032","article-title":"The Identity and Methylation Status of the First Transcribed Nucleotide in Eukaryotic MRNA 5\u2032 Cap Modulates Protein Expression in Living Cells","volume":"48","author":"Sikorski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Vogel, A.B., Kanevsky, I., Che, Y., Swanson, K.A., Muik, A., Vormehr, M., Kranz, L.M., Walzer, K.C., Hein, S., and G\u00fcler, A. (2020). A Prefusion SARS-CoV-2 Spike RNA Vaccine Is Highly Immunogenic and Prevents Lung Infection in Non-Human Primates. bioRxiv.","DOI":"10.1101\/2020.09.08.280818"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1126\/science.abi4506","article-title":"Chimeric Spike MRNA Vaccines Protect against Sarbecovirus Challenge in Mice","volume":"373","author":"Martinez","year":"2021","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.omtn.2023.07.006","article-title":"Mesenchymal Stem Cell Engineering by ARCA Analog-Capped MRNA","volume":"33","author":"Andrzejewska","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 Vaccine BNT162b1 Elicits Human Antibody and TH1 T Cell Responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 MRNA Vaccine Design Enabled by Prototype Pathogen Preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1016\/j.vaccine.2021.11.001","article-title":"Variant SARS-CoV-2 MRNA Vaccines Confer Broad Neutralization as Primary or Booster Series in Mice","volume":"39","author":"Wu","year":"2021","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified MRNA Vaccines Protect against Zika Virus Infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1172\/JCI134915","article-title":"MRNA Vaccine\u2013Induced Neoantigen-Specific T Cell Immunity in Patients with Gastrointestinal Cancer","volume":"130","author":"Cafri","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/gt.2016.46","article-title":"Therapeutic Efficacy in a Hemophilia B Model Using a Biosynthetic MRNA Liver Depot System","volume":"23","author":"DeRosa","year":"2016","journal-title":"Gene Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic Delivery of Factor IX Messenger RNA for Protein Replacement Therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/11\/1267\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:29:13Z","timestamp":1760113753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/11\/1267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["vaccines12111267"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12111267","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]}}}